XGlucoNet XGlucoNet++: A Transformer-Based, Explainable and Safe Decision Support System for Personalized Glycemic Control in Intensive Care Units
- Coordinator
- Politechnika Slaska, Poland
- Runs
- 1 June 2026 to 31 May 2028
- Status
- Running
- EU funding
- €179k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101334326
What the project is doing
In the project's own words, from its summary on CORDIS.
XGlucoNet++ aims to develop a modular, interpretable, and clinically validated AI decision support system for personalized glycemic control in Intensive Care Unit (ICU) patients. By integrating advanced transformers, reinforcement learning, and uncertainty quantification, the system will address the critical challenge of safe insulin therapy through real-time glucose forecasting and hypoglycemia risk prediction. Its hybrid architecture combines temporal deep learning, patient-specific graph representations, and evidence-aware policy learning.
Aligned with Horizon Europe’s values, the project embeds ethical AI design, subgroup fairness assessments, and open science practices. Validation will be conducted on both retrospective and prospective ICU datasets, in collaboration with clinical experts, to enhance trust, transparency, and generalizability. The fellowship will accelerate the researcher’s leadership in explainable AI for health while enabling mutual knowledge exchange with the host institution.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Politechnika Slaska | Gliwice | Poland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI